Cefalexin 125 Suspension Resmed 125 mg Powder for oral suspension
PDF Leaflet Revision Date: 26 July 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections caused by susceptible micro-organisms.
Dosage (summary)
Adults: 250 mg every 6 hours or 500 mg every 12 hours.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Uricosuric drugs
- Oral anticoagulants
- Metformin
Contraindications
- Hypersensitivity to cefalexin
- Allergy to cephalosporins
Common side effects
- Nausea
- Vomiting
- Diarrhoea
- Rash
Counselling Points
- Monitor for skin reactions
- Avoid in diabetes due to sucrose
- Report severe allergic reactions
Serious warnings
- Risk of anaphylaxis
- Pseudomembranous colitis
- Nephrotoxicity
Important Disclaimer
The Cefalexin 125 Suspension Resmed 125 mg Powder for oral suspension professional information leaflet below is the property of Resmed Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
